|
Volumn 18, Issue 5, 1995, Pages 403-406
|
The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration: A phase I clinical trial
a a a a |
Author keywords
Chemotherapy; Epidermal growth factor; Oral ulceration
|
Indexed keywords
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR;
PLACEBO;
RECOMBINANT EPIDERMAL GROWTH FACTOR;
RIFAMPICIN;
ADULT;
AGED;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DNA SYNTHESIS;
DOUBLE BLIND PROCEDURE;
DRUG CYTOTOXICITY;
DRUG EFFECT;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG SMALL CELL CANCER;
MOUTH HYGIENE;
MOUTH MUCOSA;
MOUTH ULCER;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
RECURRENT DISEASE;
ULCER HEALING;
|
EID: 0029151505
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-199510000-00009 Document Type: Article |
Times cited : (52)
|
References (0)
|